/Lists

Biotech Series C Investors & VC Firms

430 firms in this list, with a median first check of $648K. 101 of them lead rounds. Generated from verified public data and updated continuously.

Berkeley Frontier
BerkeleyPre-Seed–Late Stage
40 people
VantagePoint Capital Partners
Silicon ValleySeed–Growth$2M – $100M
18 people
DAYLI Partners
SeoulSeed–Late Stage
13 people
AIF
New YorkSeed–Growth
39 people
Novartis Venture Fund
BaselSeed–Growth$5M – $25M
22 people
Parkwalk Advisors
LondonSeed–Series C
30 people
B4 Capital
Seed–Late Stage$10M – $50M
2 people
Kaiser Permanente Ventures
San FranciscoSeed–Growth$2M – $5M
14 people
Asahi Kasei Corporate Venture Capital
Menlo ParkPre-Seed–Late Stage$200K – $5M
25 people
Rho Ventures
New YorkPre-Seed–Growth$2M – $15M
11 people
BioGeneration Ventures
NaardenPre-Seed–Late Stage
26 people
Innovation Industries
AmsterdamSeed–Growth$2.2M – $54M
25 people
Ysios Capital
BarcelonaSeed–Growth$5.4M – $21.6M
26 people
Echo Health Ventures
PortlandSeed–Growth
25 people
Roche Venture Fund
BaselSeed–Growth$648K – $3.2M
8 people
Ahren Innovation Capital
Cambridge, CambridgeshirePre-Seed–Growth
29 people
Argonautic Ventures
New YorkPre-Seed–Growth$5M
11 people
McWin Capital Partners
LondonSeries B–Growth
32 people
Antler Australia
SydneyPre-Seed–Series C$3M – $10M
17 people
Lumira Ventures
TorontoSeed–Growth$1M – $10M
17 people
Gilde Healthcare
UtrechtSeed–Late Stage$1.1M – $55M
26 people
Safar Partners
CambridgePre-Seed–Series C
17 people
Kinnevik
StockholmSeed–Growth
20 people
EcoR1 Capital
San FranciscoSeed–Late Stage
17 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.